0001658021-22-000002.txt : 20221222 0001658021-22-000002.hdr.sgml : 20221222 20221222141410 ACCESSION NUMBER: 0001658021-22-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221222 DATE AS OF CHANGE: 20221222 EFFECTIVENESS DATE: 20221222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: General Oncology, Inc. CENTRAL INDEX KEY: 0001658021 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-343809 FILM NUMBER: 221481514 BUSINESS ADDRESS: STREET 1: 67 SOUTH BEDFORD STREET, SUITE 400W CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-468-4646 MAIL ADDRESS: STREET 1: 67 SOUTH BEDFORD STREET, SUITE 400W CITY: BURLINGTON STATE: MA ZIP: 01803 D/A 1 primary_doc.xml X0708 D/A LIVE 0001658021 General Oncology, Inc. 67 SOUTH BEDFORD STREET, SUITE 400W BURLINGTON MA MASSACHUSETTS 01803 617-468-4646 DELAWARE None None Corporation true Gregg Goldstein c/o General Oncology, Inc. 67 South Bedford Street, Suite 400W Burlington MA MASSACHUSETTS 01803 Executive Officer Director Arnold Glazier c/o General Oncology, Inc. 67 South Bedford Street, Suite 400W Burlington MA MASSACHUSETTS 01803 Executive Officer Director Jeffrey Aaron Glazier c/o General Oncology, Inc. 67 South Bedford Street, Suite 400W Burlington MA MASSACHUSETTS 01803 Executive Officer Michael D. Sigman c/o General Oncology, Inc. 67 South Bedford Street, Suite 400W Burlington MA MASSACHUSETTS 01803 Director Michael J. Petit c/o General Oncology, Inc. 67 South Bedford Street, Suite 400W Burlington MA MASSACHUSETTS 01803 Director Pharmaceuticals Decline to Disclose 06b true 0001658021-22-000001 2019-06-25 true true false 0 7500000 3203721 4296279 false 31 0 0 0 false General Oncology, Inc. /s/ Gregg Goldstein Gregg Goldstein President 2022-12-22